Skip to main content
. Author manuscript; available in PMC: 2009 Nov 25.
Published in final edited form as: Genet Med. 2008 Apr;10(4):278–289. doi: 10.1097/GIM.0b013e31816b4420

Table 2.

Summary of V6 oligo array hybridization

No. clones
Min. size (Mb)
Ave. log2 ratio
Case no. Abnormality Region Change BAC Oligo BAC Oligo BAC Oligo Concordant
BAC V5 vs. Oligo V6
 B5-1 dup(22)(q11.2) 22q11.2 Gain 1 1 0.17 0.17 0.377 0.408 Yes
 B5-2 Familial CNV 19q13.4 Gain 2 2 0.91 0.91 0.261 0.439 Yes
 B5-3 Familial CNV 11q24.3 Gain 1 1 0.19 0.19 0.420 0.519 Yes
ins(13;14)a 13:q21.31 Loss 0 1b NA 0.13 NA −0.950 Addb
14:q23.1-q23.3 Gain 1 2b ~0.1 3.07 0.324 0.570 Yes
 B5-4 Trisomy 21 21 Gain 13 of 16c 19b WC WC 0.408 0.537 Yes
 B5-6 iso(18p) 18p Gain 18 18 14.14 14.14 0.639 0.966 Yes
 B5-7 der(4)t(4;8) 4p16 Loss 10 10 3.39 3.39 −0.289 −0.755 Yes
8p23 Gain 4c 6b 6.45 6.45 0.219 0.578 Yes
 B5-8 PWS/AS del 15q11.2-q12 Loss 8b 7 3.95 3.95 −0.498 −0.893 Yes
 B5-9 del(2)(q14q21)d 2q21.1-q21.3 Loss 1 3b 0.17 6.97 −0.571 −1.029 Yes
 B5-10 WBS del 7q11.23 Loss 9 6b 1.08 0.99 −0.318 −0.849 Yes
Familial CNV 7q36.1 Gain 1 1 0.14 0.14 0.318 0.527 Yes
 B5-11 mar(8) 8p11.2-q11.2 Gain 4 4 7.46 7.46 0.424 0.734 Yes
 B5-12 STS dup Xp22.31 Gain 3 3 0.85 0.85 0.415 0.601 Yes
 B5-13 der(6)t(6;10) 6q27 Loss 1 4b 0.13 1.58 −0.455 −0.861 Yes
10q24.31-q26.3 Gain 16 23b 31.26 32.57 0.392 0.516 Yes
 B5-14 WHS del 4p16.3-p16.2 Loss 12 12 4.84 4.84 −0.604 −0.774 Yes
 B5-15 der(13)t(1;13) 1p36.33-p36.32 Gain 7 4 3.22 3.22 0.340 0.432 Yes
13q34 Loss 10 10 9.20 9.20 −0.562 −0.910 Yes
 B5-16 del(5)(p15.32p14.2)d 5p15.31-p14.3 Loss 2 4b 1.18 10.89 −0.525 −0.966 Yes
 B5-17 mos +13 13 Gain 20 47b,c WC WC 0.074 0.114 Yes
BAC V6 vs. Oligo V6
 B6-1 mos 45,X/46,XX X Loss 119 111b WC WC −0.056 −0.092 Yes
 B6-2 Familial CNV 7p22.2 Gain 1 1 0.18 0.18 0.388 0.540 Yes
 B6-6 del(12)(q13.2q13.3)d 12q13.3 Loss 1 1 0.13 0.13 −0.477 −0.952 Yes
 B6-9 Possible CNV 18q23 Gain 1 1 0.20 0.20 0.279 0.388 Yes
 B6-18 dup(22)(q11.2) 22q11.2 Gain 1 1 0.17 0.17 0.452 0.429 Yes
 B6-21 dup(8)(p23.3p23.2) 8p23.3 Gain 3 3 3.47 3.47 0.355 0.607 Yes
Parallel clinical validation
 C5 dup(X)(p11.23p11.22) Xp11.23-p11.22 Gain 4 4 5.22 5.22 0.133e 0.533 Yes?
 C15 Familial CNV 5q23.1 Gain 1 1 0.15 0.15 0.223 0.222 Yes
 C17 Familial CNV 16p13.3 Gain 1 1 0.16 0.16 0.273 0.271 Yes
 C21 PMD del Xq22.2 Loss 3 3 0.76 0.76 −0.226 −0.801 Yes
 C28 STS dup Xp22.31 Gain 3 3 0.85 0.85 0.504 0.747 Yes
 C34 WBS del 7q11.23 Loss 8 6b 1.08 0.99 −0.364 −0.594 Yes
 C35 ins(6;X) 6q25 Loss 3 3 3.69 3.69 −0.428 −0.923 Yes
Xq28 Gain 4 4 1.13 1.13 0.404 0.808 Yes
 C37 Possible CNV 18:q11.1 Gain (1) 1 NA 0.051 −0.011f 0.203 Addg
 C40 47,XXX X Gain 104 of 119c 110b WC WC 0.194 0.508 Yes
 C38 del(9)(q33.3q34.1) 9q33.3-q34.1 Gain 2 2 1.64 1.64 0.263 0.267 Yes
 C42 Familial CNV 15q13.3 Gain 1 1 0.22 0.22 0.320 0.485 Yes
 C45 dup(1)(q42.3) 1q42.3 Gain 2 2 0.83 0.83 0.322 0.512 Yes
 C47 Familial CNV 7q22.1 Loss 1 1 NA 0.047 −0.147e −0.468 Yesg
 C48 PWS/AS BP1-BP2 15q11.2 Loss 2 2 0.30 0.30 −0.309 −0.681 Yes
 C50 del(6)(q25.2q25.3) 6q25.2-q25.3 Loss 4 4 5.20 5.20 −0.385 −0.813 Yes
 C57 Familial CNV 6q11.1c Loss (1) 1 NA 0.015 −0.071f −0.528 Addg
 C60 mos inv dup(15) 15q11.2-q13.3 Gain 4 of 10c 9b 8.88 8.88 0.706 1.336 Yes
 C63 Familial CNV 13q31.3 Loss 1 1 0.17 0.17 −0.320 −0.850 Yes
a

FISH analysis showed abnormality.

b

Change in no. of clones on array.

c

Not all BACs show gain.

d

Chromosome analysis showed larger abnormality.

e

BAC not at threshold.

f

Not detected by BAC array.

g

Partial gain or loss on oligo array.

Add, additional findings; WC, whole chromosome.